Search research articles
Contact Us
Filters
Showing results (51-60 of 94) with videos related to
Page
of 10
Sort By:
Plos One
|
April 8, 2015
Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis
Gabriela Avila-Pedretti, Jesús Tornero, Antonio Fernández-Nebro, et al.
International Journal of Molecular Sciences
|
September 27, 2025
Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases
Cristina Valero-Martínez, Marisa Pardines-Ortiz, Nuria Montes, et al.
Frontiers in Immunology
|
July 18, 2019
A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis
Adrià Aterido, Juan D Cañete, Jesús Tornero, et al.
Medicine
|
June 29, 2017
Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts
Benjamín Fernández-Gutiérrez, Pedro P Perrotti, Javier P Gisbert, et al.
Annals of the Rheumatic Diseases
|
June 27, 2009
Loss of imprinting of IGF2 characterises high IGF2 mRNA-expressing type of fibroblast-like synoviocytes in rheumatoid arthritis
Alejandro Martin-Trujillo, Johanna G I van Rietschoten, Trieneke C G Timmer, et al.
Pharmacogenomics
|
May 9, 2013
GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis
Isabel Acosta-Colman, Núria Palau, Jesús Tornero, et al.
BMC Medicine
|
September 10, 2016
Urine metabolome profiling of immune-mediated inflammatory diseases
Arnald Alonso, Antonio Julià, Maria Vinaixa, et al.
Reumatologia Clinica
|
June 9, 2015
2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis
Raimon Sanmartí, Susana García-Rodríguez, José María Álvaro-Gracia, et al.
Seminars in Arthritis and Rheumatism
|
May 20, 2020
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
Xabier Michelena, Helena Borrell, Mireia López-Corbeto, et al.
BMC Musculoskeletal Disorders
|
April 22, 2021
Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
Antonio Julià, María López-Lasanta, Francisco Blanco, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 94) with videos related to
Sort By:
Page
of 10
Plos One
|
April 8, 2015
Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis
Gabriela Avila-Pedretti, Jesús Tornero, Antonio Fernández-Nebro, et al.
International Journal of Molecular Sciences
|
September 27, 2025
Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases
Cristina Valero-Martínez, Marisa Pardines-Ortiz, Nuria Montes, et al.
Frontiers in Immunology
|
July 18, 2019
A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis
Adrià Aterido, Juan D Cañete, Jesús Tornero, et al.
Medicine
|
June 29, 2017
Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts
Benjamín Fernández-Gutiérrez, Pedro P Perrotti, Javier P Gisbert, et al.
Annals of the Rheumatic Diseases
|
June 27, 2009
Loss of imprinting of IGF2 characterises high IGF2 mRNA-expressing type of fibroblast-like synoviocytes in rheumatoid arthritis
Alejandro Martin-Trujillo, Johanna G I van Rietschoten, Trieneke C G Timmer, et al.
Pharmacogenomics
|
May 9, 2013
GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis
Isabel Acosta-Colman, Núria Palau, Jesús Tornero, et al.
BMC Medicine
|
September 10, 2016
Urine metabolome profiling of immune-mediated inflammatory diseases
Arnald Alonso, Antonio Julià, Maria Vinaixa, et al.
Reumatologia Clinica
|
June 9, 2015
2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis
Raimon Sanmartí, Susana García-Rodríguez, José María Álvaro-Gracia, et al.
Seminars in Arthritis and Rheumatism
|
May 20, 2020
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
Xabier Michelena, Helena Borrell, Mireia López-Corbeto, et al.
BMC Musculoskeletal Disorders
|
April 22, 2021
Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
Antonio Julià, María López-Lasanta, Francisco Blanco, et al.
Page
of 10